Best Peptides to Stack with Tirzepatide & Retatrutide in 2026

Why Stack Peptides with GLP-1 Agonists?

GLP-1 receptor agonists like Semaglutide, Tirzepatide, and Retatrutide are powerfully effective for weight loss — but they come with trade-offs. The most significant concerns reported by users and clinicians include GI side effects (nausea, constipation), muscle mass loss during rapid weight loss, and metabolic adaptation that can slow progress over time.

Strategic peptide stacking aims to address these trade-offs: protecting the gut, preserving lean mass, optimizing metabolism, and supporting overall health during aggressive weight loss protocols.

The GLP-1 Side Effect Problem

Top 5 Peptides to Stack with GLP-1 Agonists

1. BPC-157 — Gut Protection & GI Side Effect Management

BPC-157 is the most logical companion to any GLP-1 protocol. As a gastric-derived peptide with extensive gut-healing research, it directly addresses the most common complaint from GLP-1 users: GI distress.

• Why it stacks: Protects gastric lining, reduces inflammation in the GI tract, promotes healing of NSAID-induced and stress-induced gut damage
• Research basis: Animal studies show BPC-157 protects against multiple types of gastrointestinal damage while promoting mucosal healing
• Typical research dose: 250-500 mcg/day, oral or subcutaneous

2. CJC-1295/Ipamorelin — Muscle Preservation & Body Composition

One of the biggest risks of rapid GLP-1-driven weight loss is losing muscle along with fat. CJC-1295 combined with Ipamorelin provides a pulsatile growth hormone release that supports lean mass preservation and recovery.

• Why it stacks: Supports muscle protein synthesis, improves body composition (fat-to-lean ratio), enhances recovery from exercise
• Research basis: Growth hormone secretagogues have been shown to preserve lean mass during caloric restriction in clinical settings
• Note: Ipamorelin is currently FDA Category 2 — check current regulatory status before sourcing through compounding channels

3. AOD-9604 — Fat-Specific Metabolic Support

AOD-9604 is a modified fragment of human growth hormone that targets fat metabolism specifically — without the broader effects of full GH therapy. It works through a different pathway than GLP-1 agonists, making it complementary rather than redundant.

• Why it stacks: Stimulates lipolysis (fat breakdown) through GH-independent pathways, may help overcome weight loss plateaus
• Research basis: AOD-9604 was originally developed as a standalone anti-obesity agent and showed fat loss without affecting blood glucose or growth parameters
• Typical research dose: 300-600 mcg/day, subcutaneous

4. MOTS-C — Mitochondrial Metabolic Regulation

MOTS-C is a mitochondrial-derived peptide that enhances cellular energy metabolism. During aggressive caloric restriction (which GLP-1 agonists effectively create), mitochondrial function can decline — MOTS-C aims to maintain metabolic efficiency even in energy-restricted states.

• Why it stacks: Improves glucose utilization, enhances exercise capacity, counteracts metabolic slowdown during weight loss
• Research basis: Animal studies show MOTS-C improves insulin sensitivity and prevents diet-induced obesity through AMPK pathway activation
• Typical research dose: 5-10 mg, 3-5x/week, subcutaneous

5. GHK-Cu — Skin Tightening During Rapid Weight Loss

Rapid fat loss often outpaces the skin's ability to remodel, leading to laxity. GHK-Cu promotes collagen and elastin synthesis, supporting skin remodeling during and after weight loss. Full GHK-Cu guide →

• Why it stacks: Directly addresses the skin laxity concern that accompanies significant weight loss
• Application: Both injectable (systemic) and topical (targeted) forms are available

Sample Stacking Protocols

For More on GLP-1 Compounds

See our comprehensive comparison: Semaglutide vs Tirzepatide vs Retatrutide: The Complete GLP-1 Bible

Related Articles